Jacob Gunterberg

Investor type:
Locations:

Social media:

Available after registration.

Past investments

  • Priothera
  • Spruce Biosciences
  • BONESUPPORT
  • Arpida AG
  • Renovis
  • Aprea
  • Immune Targeting Systems
  • Glionova
  • LTB4 Sweden
  • ChemoCentryx
  • Oncos Therapeutics
  • Gyros
  • PTC Therapeutics
  • Precirix
  • Renovo
  • Hybrigenics
  • GenSight Biologics
  • OraPharma Inc. (acquired by JNJ)
  • Pulmonx
  • Cardoz
  • Biolipox
  • InCarda Therapeutics
  • Jerini
  • Orexo
  • Nexstim
  • Five Prime Therapeutics
  • BeneChill
  • Modus Therapeutics
  • Wilson Therapeutics
  • Algeta
  • BioStratum
  • Alba Therapeutics
  • Aro Biotherapeutics
  • Carisma Therapeutics
  • Actelion Pharmaceuticals
  • Idea
  • Pharmion
  • Strongbridge Biopharma
  • CoreValve
  • Dynavax Technologies
  • SpineVision
  • Ultragenyx Pharmaceutical
  • FerroKin Biosciences
  • Resistentia Pharmaceuticals
  • Cytos
  • Doctrin
  • Rainier Therapeutics
  • Sopherion Therapeutics
  • Lumavita
  • Oncorena
  • Tisbury Pharmaceuticals
  • Nucleonics
  • Vivet Therapeutics
  • Altimmune
  • Fusion Pharmaceuticals
  • Bionaut Pharmaceuticals
  • OxThera
  • Tengion